U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.

Cover of Drugs and Lactation Database (LactMed®)

Drugs and Lactation Database (LactMed®) [Internet].

Show details

Gadoxetate

Last Revision: August 15, 2024.

Estimated reading time: 1 minute

CASRN: 135326-11-3

image 135142085 in the ncbi pubchem database

Drug Levels and Effects

Summary of Use during Lactation

Guidelines developed by North American professional organizations state that breastfeeding need not be disrupted after a nursing mother receives a gadolinium-containing contrast medium.[1-3] However, because there is no published experience with gadoxetate during breastfeeding, other agents may be preferred, especially while nursing a newborn or preterm infant.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

References

1.
Copel J, El-Sayed Y, Heine RP, et al. Committee Opinion No. 723: Guidelines for diagnostic imaging during pregnancy and lactation. Obstet Gynecol 2017;130:e210-e6. [PubMed: 28937575]
2.
American College of Radiology Committee on Drugs and Contrast Media. Administration of contrast media to breast-feeding mothers. In, ACR manual on contrast media. 2023;Version 2023:120-1. https://www​.acr.org/Clinical-Resources​/Contrast-Manual
3.
Bookwalter CA, McDonald RJ, Packard AT, et al. Contrast media in pregnant and lactating patients, from the AJR special series on contrast media. AJR Am J Roentgenol 2024. [PubMed: 39046138]

Substance Identification

Substance Name

Gadoxetate

CAS Registry Number

135326-11-3

Drug Class

Breast Feeding

Lactation

Milk, Human

Contrast Media

Diagnostic Agents

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Copyright Notice

Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.

Bookshelf ID: NBK501697PMID: 30000757

Views

Related information

Similar articles in PubMed

  • Review Gadofosveset.[Drugs and Lactation Database (...]
    Review Gadofosveset.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Gadoversetamide.[Drugs and Lactation Database (...]
    Review Gadoversetamide.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Gadobenate.[Drugs and Lactation Database (...]
    Review Gadobenate.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Gadobutrol.[Drugs and Lactation Database (...]
    Review Gadobutrol.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Gadodiamide.[Drugs and Lactation Database (...]
    Review Gadodiamide.
    . Drugs and Lactation Database (LactMed®). 2006
See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...